Renal Insufficiency  >>  Norditropin (somatropin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Norditropin (somatropin) / Novo Nordisk
NCT00184769: Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.

Completed
4
16
Europe
somatropin
Novo Nordisk A/S
Chronic Kidney Disease, Chronic Renal Insufficiency
12/05
12/05
NCT01245374 / 2009-017387-16: Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents

Checkmark
Jun 2013 - Jun 2013: 
Checkmark P4 Data
Aug 2012 - Aug 2012: P4 Data
Completed
4
103
Europe
Norditropin NordiFlex®
Novo Nordisk A/S
Growth Hormone Disorder, Growth Hormone Deficiency in Children, Foetal Growth Problem, Small for Gestational Age, Genetic Disorder, Turner Syndrome, Chronic Kidney Disease, Chronic Renal Insufficiency, Delivery Systems
04/11
04/11

Download Options